| mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
2e-05 |
| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
4e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
0.0001 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0006 |